HomeNewsBusinessEconomyCoronavirus impact: Spike in unemployment rate in March points to more pain for Indian economy

Coronavirus impact: Spike in unemployment rate in March points to more pain for Indian economy

Surveys conducted by the Reserve Bank of India have painted a grim outlook on industries and consumer confidence.

April 07, 2020 / 16:01 IST
Story continues below Advertisement
Representative image
Representative image

With the coronavirus outbreak severely affecting every country, its impact on an already hobbling Indian economy is set to be devastating if the latest data on unemployment rate is taken as an indicator.

The Centre for Monitoring Indian Economy (CMIE) has said that the unemployment rate shot up in March. According to Mahesh Vyas, Managing Director and CEO of CMIE, the employment rate in the economy fell to an all-time low of 38.2 percent in March 2020.

Story continues below Advertisement

The Labour Participation Rate (LPR) in March 2019 was 42.7 percent. This is the first time the LPR has fallen below 42 percent, CMIE said.

"We had feared a fall in labour participation rate because of the national shutdown to contain the spread of coronavirus. But this fall seems to have happened even before the lockdown. Of course, it gets much worse as we move into the lockdown," Vyas wrote on Tuesday. The unemployment rate is now over 23 percent.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show